Briefly, 200 μg/mL NVs or 20 μg/mL Atezolizumab and Magrolimab were thoroughly mixed with 1 × 106 MDA‐MB‐231 cells for 30 min to bind PD‐L1 and CD47 expressed on tumour cells. Here, CD47 is linked to neoplasm.